Table of Contents Table of Contents i Introduction 1 1 Definition of The Pharmaceutical Industry 1 2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2 3 Forces of Competition 3 4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4 5 Role of Information Systems & Technology 4 6 GlaxoSmithKline 5 7 United Drug 6 7.1 Company Overview
Premium Pharmaceutical industry Pharmacology Drug discovery
The global pharmaceutical industry Introduction Pharmaceutical industry is the one of big revenue business in the world. There are lots of company gains a lot of profit and market share in this industry. Most of those companies were established in 19 century and early 20 century. This study explains their model development process of pharmaceutical industry‚ it details some issue like Thalidomide tragedy in 1970’s and legislation‚ then decreases the risk of side effect and protects the patient
Premium Economics Form of government Marketing
1 Snack-Food Industry – Driving factors The snack food industry benefited from increased demand for several of the industry’s products during the past five years in line with rising household disposable income. In addition the industry has a moderate level of market share concentration. The top four players are accounting 43% of revenue. This revenue depends on numerous reasons and factors. One are the changing eating habits due to less frequent restaurant dining and hurried lifestyles
Premium Snack food Meal
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
A. Introduction Pfizer‚ US pharmaceutical company is one of the largest pharmaceutical companies in the world. Unfortunately‚ Pfizer faced challenges by macro-environment forces that affect their sales volume decline dramatically in 2011. PESTEL‚ Porter’s Five Forces and Industry Lift Cycle frameworks to be applied to analysis the broad macro-environment that affected Pfizer in the pharmaceutical industry. 1. PESTEL framework PESTEL (Appendix I) is classifies into six environmental influences
Premium Pharmaceutical industry Pharmacology Food and Drug Administration
Industry Analysis of pharmaceutical industry. Prepared for- Shahnoor lecturer Daffodil International University Prepared by- Name ID Ruhul Amin 113-11- MD. Tuammel Hossain 113-11-2190 Amina Afrin 113-11-2244 Arshad Pharmaceutical Industry of Bangladesh Abstract Pharmaceutical is the core of Bangladesh’s Healthcare
Premium Pharmaceutical industry Pharmacology Generic drug
1) PHARMACEUTICAL INDUSTRY ANALYSIS 1.1 Industry Background: The total industry can broadly be classified into two categories. Theses are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production
Premium Pharmaceutical industry Pharmacology Patent
Stringent government regulation and powerful purchaser pressures. • Governments focused on pharmaceuticals in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic • European free trade agreements. Social • Ageing populations create pressure on healthcare systems. • Epidemic or chronic diseases (e.g. obesity). Technological • Impact of genetic research on industry. • Utilizing a web of alliances to address multiple customer needs Environmental
Premium Generic drug Pharmaceutical industry Regulation
The Global Pharmaceutical Industry In the pharmaceutical industry market segments can be found depending on the criteria used. For example‚ geographically there are three main market segments (the Triad accounting for 80% and with the strongest growth): The United States of America‚ Europe and Japan with the main future segment being the least developed countries. Another way of classifying the market segments that the pharmaceutical industries face is by those products directed to primary care
Premium Pharmaceutical industry Pharmacology Generic drug